Aprea Therapeutics Inc. (NASDAQ: APRE) Stock Information | RedChip

Aprea Therapeutics Inc. (NASDAQ: APRE) Listen to this Section


$3.23
-0.0200 ( -0.62% ) 10.2K

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).

Market Data


Open


$3.23

Previous close


$3.25

Volume


10.2K

Market cap


$18.52M

Day range


$3.23 - $3.45

52 week range


$3.20 - $8.85

Insider Ownership Transactions

Total Amount Purchased: -16,230.00 | $ -52,422.90

Date Type Amount Purchased Purchaser
2024-06-21 Sale -1045.00 HENNEMAN JOHN B III
2024-06-21 Sale -1045.00 Seizinger Bernd R.
2024-06-21 Sale -1045.00 Grissinger Michael
2024-06-21 Sale -1045.00 Duey Marc
2024-06-21 Sale -1045.00 Pamukcu Rifat
2024-06-21 Sale -1045.00 Peters Richard
2024-05-02 Sale -6730.00 Mirza Nadeem Q.
2024-03-28 Sale -6725.00 Gilad Oren
2024-03-28 Sale -3365.00 Hamill John P.
2024-03-14 Buy 6860.00 Seizinger Bernd R.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 44 Aug 12, 2024
8-k 8K-related 52 Aug 12, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
8-k 8K-related 13 Jun 20, 2024
8-k 8K-related 51 Jun 17, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.